Light Mode
$48.93 ↓ -0.21 (-0.42%) Trading Down from the previous close of $49.13, $0.64 below the day’s high of $49.57
-1.77 (-3.48%) / 6M
Momentum, market sentiment, and recent alerts
GSK reads not so good: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is +6.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the following segments: Commercial Operations and Total Research and Development. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in London, the United Kingdom.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.